How we work

A structured R&D pathway from screening to prototype testing

BioGntx researcher at work in the lab

01. How it works

From first call to commercial application.

Each collaboration follows a structured R&D pathway designed to assess technical feasibility step by step. Each phase has a clear objective, defined outputs and a decision point before further development is considered.

4
Steps from first definition to next-pathway decision
NDA
Confidentiality from the second conversation onward
R&D
Lab-scale prototypes for evaluation, not GMP production
License
Time-limited option after validation

02. The pathway

Four steps, one clear route.

  1. 01

    Define

    Understand the active, target product format and formulation challenge.

  2. 02

    Feasibility

    Define the formulation approach, development objectives and success criteria.

  3. 03

    Develop & characterize

    Develop and characterize an R&D-scale prototype against agreed criteria.

  4. 04

    Next pathway

    Based on the results, determine whether further optimization, co-development, technology transfer or future licensing is appropriate.

Partner with BioGntx.

Have a difficult-to-formulate lipophilic active? Let's explore whether a feasibility project, prototype-development program or technical collaboration could be the right next step.

Start a feasibility discussion